ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Pancreas Transplant Recipients with End-Stage Renal Disease Benefit from Kidney Transplantation

Y. Tang, Z. Zhu, S. Huang, Z. Zhang, W. Ju, Z. Guo, X. He, G. Chen.

Organ Transplant Center, The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, Guangdong, China.

Meeting: 2018 American Transplant Congress

Abstract number: 480

Keywords: Kidney transplantation, Pancreas transplantation, Survival

Session Information

Date: Tuesday, June 5, 2018

Session Name: Concurrent Session: Pancreas and Islet - 2

Session Time: 2:30pm-4:00pm

 Presentation Time: 2:30pm-2:42pm

Location: Room 4C-3

Related Abstracts
  • Liver Transplant Recipients with End-Stage Renal Disease Largely Benefit from Kidney Transplantation
  • Incidence, Determinants and Outcome of Kidney Transplantation for End Stage Renal Disease After Heart Transplantation

Background: End-stage renal disease (ESRD) has been shown after pancreas transplant alone (PTA), however, the benefit of kidney transplantation (KT) in PTA recipients with ESRD remains unknown. We aimed to evaluate kidney transplant survival benefit in previous pancreatic transplant recipients (KAP) compared to primary isolated (KA1) or repeat isolated kidney (KA2) transplant.

Methods: All elective kidney transplants performed for the period 1995-2013 recorded in the Scientific Registry of Transplant Recipients database were evaluated. Kaplan-Meier analysis was used to compare patient and graft survival among KAP, KA1 and KA2 groups and multivariate Cox regression models were used to assess the adjusted effect of donor and recipient covariates.

Results: Candidates with previous PTA remaining on the kidney transplant wait list have a significantly lower adjusted 3-year patient survival than receiving kidney transplantation (HR = 6.456, 95% CI = 2.646-9.749, P<0.001). The adjusted 10-year kidney graft survival in KA2 patients was the worst (HR=1.197, 95% CI: 1.144-1.252, P<0.001), however, there was no difference between KAP and KA1 (P=0.764). KAP from deceased kidney donors had a significantly inferior 10-year patient survival comparing to those from living kidney donors ( P<0.001)

Conclusion: PTA recipients with ESRD obtained a significant survival benefit after KT compared to those who remain on the waiting list. KAP recipients can achieve similar post kidney transplant survival as a KA1 recipients.

CITATION INFORMATION: Tang Y., Zhu Z., Huang S., Zhang Z., Ju W., Guo Z., He X., Chen G. Pancreas Transplant Recipients with End-Stage Renal Disease Benefit from Kidney Transplantation Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Tang Y, Zhu Z, Huang S, Zhang Z, Ju W, Guo Z, He X, Chen G. Pancreas Transplant Recipients with End-Stage Renal Disease Benefit from Kidney Transplantation [abstract]. https://atcmeetingabstracts.com/abstract/pancreas-transplant-recipients-with-end-stage-renal-disease-benefit-from-kidney-transplantation/. Accessed January 21, 2021.

« Back to 2018 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Safety of Statin Therapy After Liver Transplantation.
  • Simultaneous Heart and Kidney Transplant vs Heart Transplant: Single Center Review of Candidate Selection and List Management.
  • Safety and Effectiveness of Valganciclovir for Cytomegalovirus Prophylaxis in Solid Organ Transplant Patients on Hemodialysis
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Safety of Statin Therapy After Liver Transplantation.
  • Safety and Effectiveness of Valganciclovir for Cytomegalovirus Prophylaxis in Solid Organ Transplant Patients on Hemodialysis

    Visit Our Partner Sites

    American Transplant Congress (ATC)

    Visit the official site for the American Transplant Congress »

    American Journal of Transplantation

    The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

    American Society of Transplantation (AST)

    An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

    American Society of Transplant Surgeons (ASTS)

    The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

    Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

    Privacy Policy

    loading Cancel
    Post was not sent - check your email addresses!
    Email check failed, please try again
    Sorry, your blog cannot share posts by email.
    This site uses cookies: Find out more.